
    
      A randomised, double-blind placebo controlled study of the efficacy of chloroquine or
      sulphadoxine-pyrimethamine alone and in combination with primaquine or artesunate for the
      treatment of uncomplicated falciparum malaria.

      Arms:

        1. CQ

        2. CQ+primaquine

        3. CQ+ artesunate

        4. SP

        5. SP+primaquine

        6. SP+artesunate

      Patients were allocated to treatment groups using a pseudo-randomised table split by age and
      sex.

      Primary outcomes:

        -  Clinical and parasitological cure/treatment failure by day 28.

      Secondary outcomes:

        -  time to resolution of fever

        -  time to clearance of trophozoites

        -  time to clearance of gametocytes

        -  gametocyte carriage on or after day 7 after treatment

      All clinical assessments and slide readings were carried out by staff blind to treatment arm.
      Slides were double read.
    
  